| |
ISVHLD: Ledipasvir/Sofosbuvir Single Tablet Regimen Is Effective in Patients With HCV Genotype 2 Infection
|
| |
| |
Reported by Jules Levin
ISVHLD 2015, Berlin, Germany
15th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), June 26-28
Edward J. Gane,1 Robert H. Hyland,2 Yin Yang,2 Evguenia Svarovskaia,2
Phillip S. Pang,2 John G. McHutchison,2 Catherine A. Stedman3
1Auckland Clinical Studies, Auckland, New Zealand; 2Gilead Sciences, Inc., Foster City, California, USA; 3Christchurch Clinical Studies Trust Ltd, Christchurch, New Zealand
|
|
| |
| |
|
|
|
